1. Home
  2. WEYS vs ALDX Comparison

WEYS vs ALDX Comparison

Compare WEYS & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WEYS
  • ALDX
  • Stock Information
  • Founded
  • WEYS 1906
  • ALDX 2004
  • Country
  • WEYS United States
  • ALDX United States
  • Employees
  • WEYS N/A
  • ALDX N/A
  • Industry
  • WEYS Apparel
  • ALDX Biotechnology: Pharmaceutical Preparations
  • Sector
  • WEYS Consumer Staples
  • ALDX Health Care
  • Exchange
  • WEYS Nasdaq
  • ALDX Nasdaq
  • Market Cap
  • WEYS 365.5M
  • ALDX 319.4M
  • IPO Year
  • WEYS N/A
  • ALDX 2014
  • Fundamental
  • Price
  • WEYS $36.03
  • ALDX $4.81
  • Analyst Decision
  • WEYS
  • ALDX Strong Buy
  • Analyst Count
  • WEYS 0
  • ALDX 2
  • Target Price
  • WEYS N/A
  • ALDX $10.00
  • AVG Volume (30 Days)
  • WEYS 18.0K
  • ALDX 544.4K
  • Earning Date
  • WEYS 11-05-2024
  • ALDX 11-07-2024
  • Dividend Yield
  • WEYS 2.93%
  • ALDX N/A
  • EPS Growth
  • WEYS N/A
  • ALDX N/A
  • EPS
  • WEYS 3.02
  • ALDX N/A
  • Revenue
  • WEYS $290,409,000.00
  • ALDX N/A
  • Revenue This Year
  • WEYS N/A
  • ALDX N/A
  • Revenue Next Year
  • WEYS N/A
  • ALDX $25.36
  • P/E Ratio
  • WEYS $11.68
  • ALDX N/A
  • Revenue Growth
  • WEYS N/A
  • ALDX N/A
  • 52 Week Low
  • WEYS $27.05
  • ALDX $2.43
  • 52 Week High
  • WEYS $41.05
  • ALDX $6.55
  • Technical
  • Relative Strength Index (RSI)
  • WEYS 50.84
  • ALDX 44.70
  • Support Level
  • WEYS $34.24
  • ALDX $4.09
  • Resistance Level
  • WEYS $39.00
  • ALDX $5.01
  • Average True Range (ATR)
  • WEYS 1.63
  • ALDX 0.40
  • MACD
  • WEYS -0.25
  • ALDX -0.03
  • Stochastic Oscillator
  • WEYS 34.64
  • ALDX 43.64

About WEYS Weyco Group Inc.

Weyco Group Inc is a company, engaged in the manufacturing, designing, and distribution of footwear. The company designs and markets footwear for men, women, and children. It markets its apparel, accessories, and footwear under the brand names of Florsheim, Nunn Bush, Stacy Adams, BOGS, Rafters, and Forsake. The company organizes its business into two segments; the North American wholesale and the North American retail segment. The majority of the company's revenue is generated from the wholesale segment under which its products are sold to footwear, department, and specialty stores, as well as e-commerce retailers. The company has operational footprints in the United States which generates key revenue, Canada, Asia, South Africa, and Australia.

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. The company's product candidate, reproxalap, is a first-in-class treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer.

Share on Social Networks: